Medicare Enrolled
Dr. William Critchlow, MD
Urology Physician · Fairview Heights, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Critchlow from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Critchlow?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Critchlow
Dr. William Critchlow is an urology physician in Fairview Heights, IL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Critchlow performed 6,293 Medicare services across 2,070 unique beneficiaries.
Between the years covered by Open Payments, Dr. Critchlow received a total of $5,564 from 46 pharmaceutical and/or device companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Critchlow is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 19% volume in IL
$5,564 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,293
Medicare services
Top 19% in IL for urology physician
2,070
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~524 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,525 | $0 | $1 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
656 | $2 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
331 | $58 | $251 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
328 | $48 | $127 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
292 | $83 | $321 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
225 | $7 | $38 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
123 | $69 | $289 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
118 | $36 | $96 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
103 | $172 | $720 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
77 | $46 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
74 | $111 | $392 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
68 | $0 | $1 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
32 | $21 | $70 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
29 | $5 | $12 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
27 | $73 | $263 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
26 | $51 | $231 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
25 | $100 | $334 |
| Laser prostate fragmentation with bleeding control This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope. |
22 | $649 | $2,277 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
22 | $253 | $812 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $133 | $419 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
21 | $104 | $378 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
19 | $119 | $1,082 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
17 | $59 | $215 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
16 | $248 | $921 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
15 | $3 | $57 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
14 | $202 | $1,014 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $351 | $1,428 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $60 | $253 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
13 | $11 | $206 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
13 | $114 | $548 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
12 | $102 | $674 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
62.0% medium
37.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,564
Total received (2018-2024)
Avg $795/year across 7 years
Top 30% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
203
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,478 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$86 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,245
2023
$1,145
2022
$946
2021
$588
2020
$253
2019
$844
2018
$544
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$240
UROGEN PHARMA, INC.
$193
ACCORD HEALTHCARE, INC.
$149
ABBVIE INC.
$101
Dendreon Pharmaceuticals LLC
$83
Bayer Healthcare Pharmaceuticals Inc.
$75
AstraZeneca Pharmaceuticals LP
$70
Ferring Pharmaceuticals Inc.
$63
SUN PHARMACEUTICAL INDUSTRIES INC.
$42
Janssen Biotech, Inc.
$33
PROCEPT BioRobotics Corporation
$31
PROGENICS PHARMACEUTICALS, INC.
$28
Astellas Pharma US Inc
$25
Axonics, Inc.
$22
Myriad Genetic Laboratories, Inc.
$20
Novartis Pharmaceuticals Corporation
$20
Boston Scientific Corporation
$19
Merck Sharp & Dohme LLC
$16
Laborie Medical Technologies Corp.
$15
Top 3 companies account for 46.7% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,473
Dendreon Pharmaceuticals LLC
$369
Sumitomo Pharma America, Inc.
$312
Janssen Biotech, Inc.
$277
Astellas Pharma US Inc
$234
Allergan, Inc.
$218
ACCORD HEALTHCARE, INC.
$193
UROGEN PHARMA, INC.
$193
ABBVIE INC.
$181
Myriad Genetic Laboratories, Inc.
$169
BOSTON SCIENTIFIC CORPORATION
$166
Olympus America Inc.
$129
PFIZER INC.
$117
Bayer Healthcare Pharmaceuticals Inc.
$117
NeoTract Inc.
$111
AbbVie Inc.
$107
Novartis Pharmaceuticals Corporation
$106
Tolmar, Inc.
$89
AstraZeneca Pharmaceuticals LP
$89
Merck Sharp & Dohme LLC
$82
TOLMAR Pharmaceuticals, Inc.
$72
Lumenis, Inc
$71
Ferring Pharmaceuticals Inc.
$63
Bayer HealthCare Pharmaceuticals Inc.
$60
Verity Pharmaceuticals Inc.
$52
SUN PHARMACEUTICAL INDUSTRIES INC.
$42
UroGen Pharma, Inc.
$40
Sun Pharmaceutical Industries Inc.
$36
Kowa Pharmaceuticals America, Inc.
$35
Travere Therapeutics, Inc.
$31
PROCEPT BioRobotics Corporation
$31
Myovant Sciences Inc.
$30
Baxter Healthcare
$29
PROGENICS PHARMACEUTICALS, INC.
$28
Laborie Medical Technologies Corp.
$26
UROVANT SCIENCES INC
$25
Axonics, Inc.
$22
Teleflex LLC
$21
PALETTE LIFE SCIENCES, INC.
$19
AbbVie, Inc.
$16
Acerus Pharmaceuticals Corporation
$15
Merck Sharp & Dohme Corporation
$14
Allergan Inc.
$14
Blue Earth Diagnostics Limited
$14
E.R. Squibb & Sons, L.L.C.
$13
COLOPLAST CORP
$13
Top 3 companies account for 38.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · AMS 700 CXR RTE Kit · AQUABEAM SYSTEM · AVYCAZ · Altis · Axonics · Axumin · BOTOX · CAMCEVI · ELIGARD · ERLEADA · Erleada · FLEXIVA · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENERAL - KIDNEY STONE DISEASE · GENERAL ERECTILE DYSFUNCTION · GREENLIGHT · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · Lumenis Pulse 120H · Lupron Depot · MYRBETRIQ · Natesto · Nubeqa · OPDIVO · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · SEGLENTIS · TISSEEL · Thiola · Trelstar · UROLIFT · UroLift · XTANDI · Xtandi · YONSA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
110
Per 100K population
43.2
County median income
$70,178
Nearest hospital
MEMORIAL HOSPITAL
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Critchlow is a clinical cardiology specialist, with above-average Medicare volume (top 19% in IL), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Critchlow experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Critchlow performed 3,525 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Critchlow receive payments from pharmaceutical companies?
Yes. Dr. Critchlow received a total of $5,564 from 46 companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Critchlow's costs compare to other urology physicians in Fairview Heights?
Dr. Critchlow's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Critchlow) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fairview Heights
Browse urology physicians in Fairview Heights ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology